Skip to main navigationSkip to main content
The University of Southampton
We're launching a new website soon and would love your feedback. See the new design
ATTACK Trial

ATTACK: ASPIRIN TO TARGET ARTERIAL EVENTS IN CHRONIC KIDNEY DISEASE

Does low-dose aspirin reduce the chance of a first heart attack or stroke in patients with chronic kidney disease (CKD)?

 

This is a large-scale academic study, being led by the University of Southampton, to see whether or not patients with chronic kidney disease should take aspirin daily to prevent a first heart attack or stroke. It is recruiting patients from GP practices across the UK, and looks to invite 198,000 patients.

Privacy Settings